CAMBRIDGE, Mass.--(BUSINESS WIRE)--Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, announced today that company scientists made presentations at two premier scientific conferences. These presentations highlighted progress with the Company’s lead programs in cystic fibrosis (CF) and Parkinson’s disease (PD) and demonstrated the potential of its differentiated approach to developing disease modifying therapeutics.
